Outbreak of a multiresistant Klebsiella pneumoniae strain in an intensive care unit: Antibiotic use as risk factor for colonization and infection

Clinical Infectious Diseases

Volumn 30, Issue 1, 2000, Pages 55-60

  Asensio, Angel ^a,b   Oliver, Antonio ^a   González Diego, Paulino ^a   Baquero, Fernando ^a   Pérez Díaz, Jose Claudio ^a   Ros, Purificación ^a   Cobo, Javier ^a   Palacios, Margarita ^a   Lasheras, Dolores ^a   Cantón, Rafael ^a  

^a UNIVERSITY OF ALCALÁ   (Spain)

^b NONE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZTREONAM; CEFAZOLIN; CEFEPIME; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; IMIPENEM; METRONIDAZOLE; PIPERACILLIN; VANCOMYCIN;

AGE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG USE; EPIDEMIC; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFANT; INFECTION RISK; INTENSIVE CARE UNIT; KLEBSIELLA PNEUMONIAE; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; RANDOM AMPLIFIED POLYMORPHIC DNA; SPAIN; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CASE-CONTROL STUDIES; CHILD, PRESCHOOL; CROSS INFECTION; DISEASE OUTBREAKS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; HUMANS; INFANT; INFANT, NEWBORN; INTENSIVE CARE UNITS, PEDIATRIC; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; RANDOM AMPLIFIED POLYMORPHIC DNA TECHNIQUE; RISK FACTORS;

EID: 0033979735     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/313590     Document Type: Article

References (32)

1. Emori TG, Gaynes RP. An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev 1993; 6:428-42.
2. Diagnósticos etiológicos. In: Vaqué J y Grupo de trabajo EPINE, eds. Evolución de la prevalencia de las infecciones nosocomiales en los hospitales españoles. Proyecto EPINE 1990-1997. Madrid: Sociedad Española de Higiene y Medicina Preventiva Hospitalarias, 1998:231-78.
3. Burwen DR, Banerjee SN, Gaynes RP, the National Nosocomial Infections Surveillance System. Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. J Infect Dis 1994; 170:1622-5.
4. Monnet DL, Biddle JW, Edwards JR, et al. Evidence of interhospital transmission of extended-spectrum β-lactam resistant Klebsiella pneumoniae in the United States, 1986 to 1993. Infect Control Hosp Epidemiol 1997; 18:492-8.
5. Jacoby GA, Medeiros AA. More extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1991; 35:1697-704.
6. Fernández-Rodríguez A, Cantón R, Pérez-Díaz JC, Martínez-Beltrán J, Picazo JJ, Baquero F. Aminoglycoside-modifying enzymes in clinical isolates harboring extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1992; 36:2536-8.
7. Peña C, Pujol M, Ricart A, et al. Risk factors for faecal carriage of Klebsiella pneumoniae producing extended spectrum β-lactamase (ESBL-KP) in the intensive care unit. J Hosp Infect 1997; 35:9-16.
8. Lucet JC, Chevret S, Decre D, et al. Outbreak of multiply resistant enterobacteriaceae in an intensive care unit: epidemiology and risk factors for acquisition. Clin Infect Dis 1996; 22:430-6.
9. De Champs C, Rouby D, Guelon D, et al. A case-control study of an outbreak of infections caused by Klebsiella pneumoniae strains producing CTX-1 (TEM-3) beta-lactamase. J Hosp Infect 1991; 18:5-13.
10. Quinn JP. Clinical significance of extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis 1994; 13(Suppl 1):S39-42.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections. Am J Infect Control 1988; 16:128-40.
12. National Committee for Clinical Laboratory Standards [NCCLS]. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically. 4th ed. Approved standard. NCCLS document M7-A4. Wayne, PA: NCCLS, 1997.
13. National Committee for Clinical Laboratory Standards [NCCLS]. Performance standards for antimicrobial disk susceptibility tests. 6th ed. Approved standard. NCCLS document M2-A6. Wayne, PA: NCCLS. 1997.
14. Phillips I, Shannon KP. Aminoglycosides and aminocyclitols. In: Lambert HP, O'Grady FW, Finch RG, Greenwood D, eds. Antibiotics and chemotherapy. 7th ed. New York: Churchill Livingstone, 1997:164-201.
15. Jarlier V, Nicolas MH, Fournier G, Philippon A. Extended broad-spectrum β-lactamases conferring transferable resistance to newer β-lactam agents in enterobacteriaceae: hospital prevalence and susceptibility patterns. Rev Infect Dis 1988; 10:867-78.
16. Morosini MI, Cantón R, Martinez-Beltrán J, et al. New extended-spectrum TEM-type beta-lactamase from Salmonella enterica subsp. enterica isolated in a nosocomial outbreak. Antimicrob Agents Chemother 1995; 39:458-61.
17. Gori A, Espinasse F, Deplano A, Nonhoof C, Nicolas MH, Struelens MJ. Comparison of pulsed-field gel electrophoresis and randomly amplified DNA polymorphism analysis for typing extended-spectrum β-lactamase-producing Klebsiella pneumoniae. J Clin Microbiol 1996; 34:2448-53.
18. Statistix 3.1: an interactive statistical analysis program for microcomputers. St. Paul, MN: Analytical Software, 1990.
19. Dean AG, Dean JA, Coulombier D, et al. Epi Info, version 6: a word processing, database, and statistics program for public health on IBM-compatible microcomputers. Atlanta, GA: Centers for Disease Control and Prevention, 1996.
20. Hosmer DV, Lemeshow S. Model-building strategies and methods for logistic regression. In: Hosmer DV, ed. Applied logistic regression. New York: Wiley and Sons, 1989:82-134.
21. Meyer KS, Urban C, Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993; 119:353-8.
22. Rice LB, Eckstein EC, DeVente J, Shlaes DM. Ceftazidime-resistant Klebsiella pneumoniae isolates recovered at the Cleveland Department of Veterans Affairs Medical Center. Clin Infect Dis 1996; 23:118-24.
23. Eisen D, Russell EG, Tymms M, Roper EJ, Grayson ML, Turnidge J. Random amplified polymorphic DNA and plasmid analyses used in investigation of an outbreak of multiresistant Klebsiella pneumoniae. J Clin Microbiol 1995; 33:713-7.
24. Brun-Buisson C, Legrand P, Philippon A, Montravers F, Ansquer M, Duval J. Transferable enzymatic resistance to third-generation cephalosporins during nosocomial outbreak of multiresistant Klebsiella pneumoniae. Lancet 1987; 2:302-6.
25. Yuan M, Aucken H, Hall LM, Pitt TL, Livermore DM. Epidemiological typing of klebsiellae with extended-spectrum beta-lactamases from European intensive care units. J Antimicrob Chemother 1998; 41:527-39.
26. French GL, Shannon KP, Simmons N. Hospital outbreak of Klebsiella pneumoniae resistant to broad-spectrum cephalosporins and β-lactam β-lactamase inhibitor combinations by hyperproduction of SHV-5 β-lactamase. J Clin Microbiol 1996; 34:358-63.
27. Peña C, Pujol M, Ardanuy C, et al. Epidemiology and successful control of a large outbreak due to Klebsiella pneumoniae producing extended-spectrum β-lactamases. Antimicrob Agents Chemother 1998; 42:53-8.
28. Brun-Buisson C, Legrand P, Rauss A, et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Ann Intern Med 1989; 110:873-81.
29. Paterson DL, Ko WC, Mohapatra S, et al. Klebsiella pneumoniae bacteremia: impact of extended-spectrum beta-lactamase (ESBL) production in a global study of 216 patients [abstract J-210]. In: Program and abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology, 1997: 328.
30. Schiappa DA, Hayden MK, Matushek MG, et al. Ceftazidime-resistant Klebsiella pneumoniae and Escherichia coli bloodstream infection: a case-control and molecular epidemiologic investigation. J Infect Dis 1996; 174:529-36.
31. Garner JS, Hospital Infection Control Practices Advisory Committee. Guideline for isolation precautions in hospitals. Infect Control Hosp Epidemiol 1996; 17:53-80.
32. Boyce JM. Treatment and control of colonization in the prevention of nosocomial infections. Infect Control Hosp Epidemiol 1996; 17:256-61.